Summary A number of rare human inherited syndromes are associated with apparent defects in DNA repair and a greatly increased frequency of cancer. Cell lines derived from such individuals phenotypically resemble certain bacterial mutant strains that have increased sensitivity to radiation or chemical agents and well characterised repair defects. This analogy provides leads for unravelling the molecular alterations in such cancer-prone human cells. The inducibility of DNA repair enzymes is also reviewed. Exposure of bacteria to alkylating agents, or oxygen radicals, causes the overproduction of several novel and interesting repair activities, and the induced bacteria provide an abundant source of these proteins for purification and biological characterisation. Enzymes with the same defined specificities are often present in human cells, presumably serving the same functions as in microorganisms, but these activities are only constitutively expressed at low levels.
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The major DNA repair processes appear to be universally distributed among living cells. They probably evolved at a very early stage to counteract DNA damage caused by heatinduced hydrolysis, ultraviolet light, ionising radiation, and certain reactive chemicals. The same processes continue to serve these functions in human cells, and provide important protection against many environmental mutagens and carcinogens. Since the correction pathways tend to minimise the consequences of radiation and group-specific agents acting on DNA, however, they also have the unwanted side effect of opposing the action of anticancer drugs and radiation therapy. For this reason, it is of considerable interest to elucidate in molecular detail the different individual steps in various specific repair pathways, in order to develop targeted inhibitors of DNA repair.
Similar repair functions exist in man and in genetically well characterised microorganisms such as E. coli and yeast. The stringent characterisation of the physiological roles of many DNA repair enzymes that can be performed in the model systems by appropriate mutant analysis has provided for convincing indications of the functions in vivo of several repair activities in human cells. Thus, the major cytotoxic lesion introduced in DNA on exposure of cells to simple monofunctional alkylating agents, 3-alkyladenine, is removed from the genome by exactly the same kind of excision process involving a specific 3-alkyladenine-DNA glycosylase in both E. coli and man. The data obtained with bacterial mutants defective in only this form of excision-repair provide conclusive proof for the strong cell killing effect of this particular lesion in bacteria; it seems overwhelmingly likely that the human repair enzyme with the identical biochemical specificity as the E. coli activity in vitro also serves to remove the same lesion in vivo, and that in the absence of repair, 3-alkyladenine would be a strongly cytotoxic lesion in mammalian cells exposed to alkylating agents. A final proof of this notion would require access to mammalian cell lines defective in the repair enzyme, but such mutant lines are not presently available.
A strong advantage of work with the E. coli model system is that the bacteria possess several inducible DNA repair pathways. Human cells, on the other hand, exist in a more stable environment and usually express analogous repair activities constitutively at a relatively low level. Induced E. coli cells, therefore, have served in several cases as an abundant source of interesting proteins active in DNA repair, and this has greatly facilitated the characterisation of a number of novel repair functions. For example, the *Delivered at the 28th Annual Meeting of the British Association for Cancer Research. mutagenic and carcinogenic effect of simple alkylating agents such as methylnitrosourea is primarily due to the generation of 06-alkylguanine residues in DNA, which miscode during replication and result in transition mutations (Loechler et al., 1984; Zarbl et al., 1985) . Bacterial and mammalian cells have a limited ability to counteract such mutagenesis by repairing 06-alkylguanine residues prior to DNA replication. Attempts to unravel the mechanism of this correction pathway by direct work with mammalian systems were unsuccessful. However, employing cell-free extracts from E. coli induced to produce high levels of the activity, we could show that the repair event was due to an unexpected transmethylation reaction, with direct transfer of an alkyl group from the 06 position of guanine in DNA to a cysteine residue in a protein (Olsson & Lindahl, 1980) . When this unique repair reaction had been elucidated, and a specific and quantitative assay method developed for the E. coli activity, it became a relatively simple task to demonstrate the occurrence of lower levels of an analogous enzyme activity in mammalian (including human) cell extracts (Bogden et al., 1981; Harris et al., 1983; Pegg et al., 1983) .
The adaptive response to alkylating agents The inducible repair pathway to counteract the effects of alkylating agents, the adaptive response, was discovered ten years ago at the Imperial Cancer Research Fund by Samson and Cairns (1977) . Exposure of E. coli to low, non-lethal concentrations of alkylating agents caused increased resistance to a subsequent challenge with a higher dose. This work was extended to cell-free systems by the author in collaboration with Peter Karran. We showed that the response has two major components. Induced resistance to cell killing is due to the induction of a DNA glycosylase which releases from damaged DNA a number of base derivatives that would otherwise block replication (Karran et al., 1982a; Evensen & Seeberg, 1982; McCarthy et al., 1984) . Induced resistance to mutagenesis, on the other hand, can be ascribed to the reversion of 06-alkylguanine to guanine by the above-mentioned transmethylation reaction (Lindahl, 1982; Demple et al., 1985) .
The adaptive response in E. coli is under the control of the regulatory ada gene (Jeggo, 1979) , which has been cloned and sequenced in our laboratory (Sedgwick, 1983; Teo et al., 1984; Demple et al., 1985; Nakabeppu et al., 1985) . The product of the ada gene unexpectedly turned out to be identical with the alkyl transferase acting on 06-alkylguanine (Teo et al., 1984) . Thus, the protein has at least two functions: it can act as a positive regulatory factor, and also as a DNA repair enzyme. Recent studies on the ada gene product have shown that the protein exhibits a doubledomain structure. Two active fragments with different functions can be physically separated after treatment of the protein with low concentrations of trypsin (Sedgwick & Lindahl, in preparation) . The C-terminal half of the protein serves to repair 06-alkylguanine residues in DNA, and accounts for the antimutagenic effect. In this reaction, the protein acts as its own alkyl group acceptor and is not regenerated. Consequently, the repair response is easily saturated in vivo by titration of the available protein molecules by this suicide reaction (Robins & Cairns, 1979; Lindahl et al., 1982) . The N-terminal half of the protein can also abstract an alkyl group from modified DNA to generate an S-alkylcysteine residue, but this latter alkyl group is derived from a minor (and apparently innocuous) DNA lesion, one of the two stereoisomers of a phosphotriester (McCarthy & Lindahl, 1985) . The main purpose of the second alkylation event appears to be conversion of the adaencoded protein to a transcriptional activator for the genes involved in the inducible response to alkylating agents (Teo et al., 1986; Nakabeppu & Sekiguchi, 1986) . Methylating agents such as methylnitrosoguanidine and methylnitrosourea, which frequently produce phosphotriesters in DNA, are the most effective inducers. The conformer of the Ada protein with a methylcysteine residue in its N-terminal half (the methyl group having been derived from a methylphosphotriester in DNA) binds tightly to the specific sequence d(AAANNAAAGCGCA) present in the promoter regions of genes involved in the inducible response, at a site immediately 'upstream' of the binding site for RNA polymerase (Teo et al., 1986; Sedgwick, 1987) . The DNAbinding form of the ada-encoded protein presumably facilitates transcription by a direct protein-protein interaction with the RNA polymerase.
This inducible response to alkylating agents in bacteria is of general interest in view of the fact that a novel type of control of gene expression is involved, in which the regulatory gene product requires post-translational covalent modification before it can assume the role of an efficient transcriptional activator. There is, however, no evidence for the occurrence of a similar mechanism of inducible antimutagenic DNA repair in eukaryotic cells. Treatment of human cells in tissue culture with direct-acting alkylating agents does not give rise to an increased resistance to the same agents (Karran et al., 1982b; Frosina et al., 1984; Yarosh et al., 1984) . Moreover, it has been difficult to obtain human tumour cell lines with markedly increased resistance to simple alkylating agents (Teicher et al., 1986) and the moderately improved resistance observed in certain lines after prolonged exposure to alkylating agents is very likely due to a mechanism different from that defined for inducible bacteria.
The structure of the human repair protein, 06_ alkylguanine-DNA alkyltransferase, also supports the concept of its non-inducibility: The human enzyme (24kDa) preparation has not yet been obtained from mammalian cells (Pegg et al., 1983; . For similar reasons, the gene encoding the human transferase has not been cloned, despite attempts by several research groups using a variety of approaches.
Mer-cells are not only susceptible to agents such as methylnitrosourea but also show greatly increased sensitivity to the clinically used chloroethylnitrosoureas (Zlotogorski & Erickson, 1983 (Karran, 1985; Karran & Williams, 1985) . This method may be used for transient sensitisation of tumour cell lines to chloroethylnitrosoureas (Yarosh, 1986; Dolan et al., 1986; Day et al., 1987) , but it is unclear at present if this approach will be clinically useful in the treatment of tumours with cross-linking nitrosoureas.
Repair of oxygen-induced DNA damage Potentially mutagenic or toxic DNA lesions arise accidentally as an unwanted side effect of normal oxygen metabolism. Ames (1983) has drawn attention to the large number of environmental mutagens, including substances in food, which might act through the formation of oxygen radicals. Several repair enzymes that act on DNA exposed to oxidising agents have been characterised in our laboratory: these include (i) formamidopyrimidine-DNA glycosylase, which catalyses the release of potentially cytotoxic purine residues with an opened imidazole ring from y-ray-irradiated DNA (Chetsanga & Lindahl, 1979; Boiteux & Laval, 1983; Breimer, 1984) ; (ii) a separate DNA glycosylase which releases urea (a remnant of thymine) and several other derivatives with fragmented pyrimidine rings from oxidised DNA (Breimer & Lindahl, 1980 -this enzyme is identical with endonuclease III, which removes thymine glycol from DNA (Demple & Linn, 1980) ; (iii) a Mg2 + independent endonuclease for apurinic sites in DNA, endonuclease IV (Ljungquist et al., 1976; Ljungquist, 1977; Demple et al., 1986) , which also removes 3-phosphoglycolate residues from 3' termini of damaged DNA. Two distinct DNA glycosylases with the specificities described are found both in E. coli and in human cells (Breimer, 1983 (Breimer, , 1984 . The enzyme that liberates thymine glycol and various substituted urea derivatives from DNA is particularly interesting, because this small, monomeric protein of 25 kDa can remove many different types of oxidised pyrimidine derivatives from DNA, including several y-ray-induced products (Breimer & Lindahl, 1985) . We have speculated that this enzyme might remove all pyrimidine derivatives that lack the 5,6 endocyclic double bond, with a concomitant loss of the planar ring structure necessary for effective hydrogen-bonding with the complementary DNA chain, as well as the stacking interactions with adjacent bases in the same chain. The recognition of a structural distortion, rather than some specific altered base product, provides a mechanism by which a single DNA repair enzyme can remove a large series of different base products, including many minor lesions, from DNA exposed to ionising radiation. Another example of this strategy is provided by the multi-subunit nuclease encoded by the uvr genes, which recognises the major helical distortion in DNA caused by several different bulky lesions (van Houten et al., 1986 (Demple & Halbrook, 1983; Morgan et al., 1986) . Recently, endonuclease IV (and presumably some other repair functions as well) has been found to be induced in an oxyR-independent reaction by treatment of E. coli with agents such as para-quinones, which primarily generate superoxide radicals. Induction is much less efficient with agents such as H202 or ionising radiation (Chan & Weiss, 1987 (Shiloh et al., 1982; Painter & Young, 1980) ; (iii) Fanconi's anaemia, in which cells are anomalously sensitive to oxidative DNA damage and the cross-linking agent mitomycin C; and (iv) Bloom's syndrome. The latter is characterised by severely stunted growth and sun-sensitivity in patients, and cells from such individuals show a characteristic large increase in the frequency of spontaneous sister chromatid exchange, as well as an increased frequency of chromosome breakage (Chaganti et al., 1974) . In a survey of different DNA repair enzyme activities in extracts of human lymphoid cell lines representative of these various syndromes, we observed a decrease in the level of one of the two DNA ligases of human cells, ligase I, in Bloom's syndrome cells. DNA ligase I is the main ligase active during DNA replication. Partial purification and characterisation of the enzyme from normal cells and Bloom's syndrome cells showed that the residual ligase I from the latter source was anomalously heat-labile (Willis & Lindahl, 1987) . However, no decrease in the molecular weight of the enzyme was apparent. These data suggest that the molecular alteration in Bloom's syndrome is a missense mutation in a transcribed and translated region of the gene for DNA ligase I. have also observed a ligase I with apparently unusual aggregation properties in cells from Bloom's patients. The further definition of this syndrome may now be pursued at a molecular level by cloning and sequencing the gene for DNA ligase I from normal and Bloom's syndrome cells, although human polymorphism may make this task a relatively time-consuming effort. However, it may already be concluded that the characteristic phenotype of this condition, with its observed increased spontaneous DNA recombination frequencies, can be adequately explained by a ligase defect (Willis & Lindahl, 1987) . We have now investigated 6 different lines representative of the syndrome, derived from different individuals, and all contain a defective ligase I, whereas none of 12 human control cell lines showed such an alteration (Willis et al., in preparation) .
Considerable efforts are made in many laboratories to identify the altered genes in inherited human syndromes with DNA repair defects by transfection of deficient cell lines with cloned human DNA from normal cells. The finding that Bloom's syndrome may be due to a specific enzyme defect, as revealed by direct assays with cell-free extracts, is representative of an alternative route of investigation into the molecular origins of these human diseases. This approach may now be extended to other syndromes.
